X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (68) 68
life sciences & biomedicine (65) 65
humans (55) 55
male (41) 41
middle aged (41) 41
aged (37) 37
female (37) 37
abridged index medicus (30) 30
risk factors (28) 28
double-blind method (27) 27
general & internal medicine (26) 26
cardiovascular disease (22) 22
medicine, general & internal (22) 22
cardiovascular diseases - prevention & control (20) 20
cardiovascular system & cardiology (19) 19
prevention (19) 19
rosuvastatin calcium (19) 19
cardiac & cardiovascular systems (18) 18
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (18) 18
treatment outcome (18) 18
fluorobenzenes - therapeutic use (17) 17
pyrimidines - therapeutic use (17) 17
sulfonamides - therapeutic use (17) 17
cardiovascular diseases (16) 16
health aspects (16) 16
research (16) 16
clinical trials (15) 15
incidence (15) 15
cholesterol (14) 14
statins (14) 14
follow-up studies (13) 13
heart attacks (13) 13
cholesterol, ldl - blood (12) 12
c-reactive protein (11) 11
drug therapy (11) 11
inflammation (11) 11
usage (11) 11
adult (10) 10
analysis (10) 10
c-reactive protein - metabolism (10) 10
care and treatment (10) 10
dietary supplements (10) 10
primary prevention (10) 10
myocardial infarction (9) 9
rosuvastatin (9) 9
atherosclerosis (8) 8
mortality (8) 8
stroke - prevention & control (8) 8
cancer (7) 7
cardiovascular (7) 7
cardiovascular diseases - epidemiology (7) 7
men (7) 7
myocardial infarction - prevention & control (7) 7
physiological aspects (7) 7
prospective studies (7) 7
risk (7) 7
studies (7) 7
blood pressure (6) 6
c-reactive protein - analysis (6) 6
cardiovascular diseases - mortality (6) 6
clinical medicine (6) 6
cytokines (6) 6
disease prevention (6) 6
dosage and administration (6) 6
fluorobenzenes - administration & dosage (6) 6
fluorobenzenes - adverse effects (6) 6
health risk assessment (6) 6
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (6) 6
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (6) 6
klinisk medicin (6) 6
patient outcomes (6) 6
patients (6) 6
proportional hazards models (6) 6
pyrimidines - administration & dosage (6) 6
pyrimidines - adverse effects (6) 6
stroke (6) 6
sulfonamides - administration & dosage (6) 6
sulfonamides - adverse effects (6) 6
vitamin e (6) 6
acute respiratory distress syndrome (5) 5
arteriosclerosis (5) 5
diabetes (5) 5
hypertension (5) 5
interleukins (5) 5
internal medicine (5) 5
lipids (5) 5
physicians (5) 5
primary prevention - methods (5) 5
proteins (5) 5
randomized clinical trial (5) 5
vitamin c (5) 5
vitamins - therapeutic use (5) 5
women (5) 5
aged, 80 and over (4) 4
complications and side effects (4) 4
critical care medicine (4) 4
diagnosis (4) 4
drug combinations (4) 4
evidence-based medicine (4) 4
low density lipoproteins (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 11/2008, Volume 359, Issue 21, pp. 2195 - 2207
Journal Article
by Yusuf, Salim and Sheridan, Patrick and Dagenais, Gilles and Chiasson, Jean Louis and Diaz, Rafael and Avezum, Alvaro and Lanas, Fernando and Fodor, George and Holman, Rury R and Budaj, A and Davis, M and Dinccag, N and Escalante, A and Keltai, M and Laakso, M and McQueen, M and Mohan, V and Piegas, L and Shaw, J and Teo, K and Zimmet, P and Zinman, B and Albisu, J and Balbuena, M and Bello, F and Brandani, L and Brandes, M and Bruera, D and Cabral Venere, R and Caccavo, A and Cacurri, A and Caime, G and Capozzi, M and Carrique, A and Carrique, P and Cartasegna, L and Casabe, J and Casaccia, G and Castellanos, C and Cerchi, P and Cipullo, M and Cismondi, M and Citta, L and Crespo, C and Crunger, P and De Loredo, S and Del Cerro, S and Denaro, R and Fernandez, M and Fernandez, A and Focaccia, M and Frontini, L and Gambarte, A and Garrido, M and Garrido, I and Guglielmotti, V and Hershson, A and Hoffman, V and Juarisit, G and Klyver, M and Lagrutta, M and Lowenstein, D and Lowenstein, J and Lucero, C and Luciardi, H and Luquez, C and Maffia, M and Manuale, O and Martinez, G and Memoli, R and Molina, M and Navarrete, S and Orlandini, A and Plastino, M and Pomposiello, J and Quiroga, G and Ramos, H and Reissig, F and Risolo, A and Rodrigues, H and Rodriquez, C and Sago, L and Sanchez, R and Schwindt, C and Sposetti, G and Streitenberger, P and Visco, V and Zaidman, C and Allen, C and Arsov, T and Batrouney, B and Brooks, B and Buchanan, P and Buckland, A and Chan, Y and Ching, H and Chronopoulos, A and Cohen, N and Colagiuri, S and Correcha, M and ... and unav and The DREAM Trial Investigators and DREAM Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 10/2006, Volume 355, Issue 15, pp. 1551 - 1562
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2009, Volume 360, Issue 18, pp. 1851 - 1861
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2019, Volume 380, Issue 8, pp. 752 - 762
Patients with coronary artery disease were randomly assigned to either methotrexate (15 to 20 mg weekly) or placebo. At a median of 2.3 years, there was no... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Confidence Intervals | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Interleukin-1beta - blood | Interleukin-6 - blood | Statistics, Nonparametric | Cardiovascular Diseases - mortality | Female | C-Reactive Protein - analysis | Diabetes Mellitus, Type 2 - complications | Immunosuppressive Agents - administration & dosage | Stroke - prevention & control | Double-Blind Method | Proportional Hazards Models | Coronary Artery Disease - drug therapy | Metabolic Syndrome - complications | Methotrexate - adverse effects | Myocardial Infarction - complications | Stroke - etiology | Myocardial Infarction - drug therapy | Coronary Artery Disease - complications | Immunosuppressive Agents - adverse effects | Methotrexate - administration & dosage | Transaminases - blood | Aged | Atherosclerosis - prevention & control | Myocardial infarction | C-reactive protein | Heart attacks | Liver | Hematocrit | Cardiovascular disease | Angina | Metabolic syndrome | Folic acid | Interleukin 6 | Proteins | Atherosclerosis | Methotrexate | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cerebral infarction | Cytokines | Diabetes mellitus | Inflammation | IL-1β | Patients | Investigations | Disease prevention | Rheumatoid arthritis | Arteriosclerosis | Monoclonal antibodies | Diabetes | Health risk assessment | Metabolic disorders | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
by Postmus, Iris and Trompet, Stella and Deshmukh, Harshal A and Barnes, Michael R and Li, Xiaohui and Warren, Helen R and Chasman, Daniel I and Zhou, Kaixin and Arsenault, Benoit J and Donnelly, Louise A and Wiggins, Kerri L and Avery, Christy L and Griffin, Paula and Feng, QiPing and Taylor, Kent D and Li, Guo and Evans, Daniel S and Smith, Albert V and de Keyser, Catherine E and Johnson, Andrew D and de Craen, Anton J. M and Stott, David J and Buckley, Brendan M and Ford, Ian and Westendorp, Rudi G. J and Eline Slagboom, P and Sattar, Naveed and Munroe, Patricia B and Sever, Peter and Poulter, Neil and Stanton, Alice and Shields, Denis C and O’Brien, Eoin and Shaw-Hawkins, Sue and Ida Chen, Y.-D and Nickerson, Deborah A and Smith, Joshua D and Pierre Dubé, Marie and Matthijs Boekholdt, S and Kees Hovingh, G and Kastelein, John J. P and McKeigue, Paul M and Betteridge, John and Neil, Andrew and Durrington, Paul N and Doney, Alex and Carr, Fiona and Morris, Andrew and McCarthy, Mark I and Groop, Leif and Ahlqvist, Emma and Bis, Joshua C and Rice, Kenneth and Smith, Nicholas L and Lumley, Thomas and Whitsel, Eric A and Stürmer, Til and Boerwinkle, Eric and Ngwa, Julius S and O’Donnell, Christopher J and Vasan, Ramachandran S and Wei, Wei-Qi and Wilke, Russell A and Liu, Ching-Ti and Sun, Fangui and Guo, Xiuqing and Heckbert, Susan R and Post, Wendy and Sotoodehnia, Nona and Arnold, Alice M and Stafford, Jeanette M and Ding, Jingzhong and Herrington, David M and Kritchevsky, Stephen B and Eiriksdottir, Gudny and Launer, Leonore J and Harris, Tamara B and Chu, Audrey Y and Giulianini, Franco and MacFadyen, Jean G and Barratt, Bryan J and Nyberg, Fredrik and Stricker, Bruno H and Uitterlinden, André G and Hofman, Albert and Rivadeneira, Fernando and Emilsson, Valur and Franco, Oscar H and Ridker, Paul M and Gudnason, Vilmundur and Liu, Yongmei and Denny, Joshua C and Ballantyne, Christie M and Rotter, Jerome I and Adrienne Cupples, L and Psaty, Bruce M and Palmer, Colin N. A and Tardif, Jean-Claude and Colhoun, Helen M and Hitman, Graham and ... and Data and Analysis Group and DNA, Genotyping, Data QC and Informatics Group and Welcome Trust Case Control Consortium and Membership of Wellcome Trust Case Control Consortium and Publications Committee and Welcome Trust Case Control Consort and Sahlgrenska akademin and Göteborgs universitet and Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för arbets-och miljömedicin and Gothenburg University and Institute of Medicine, Department of Public Health and Community Medicine, Section of Occupational and environmental medicine and Sahlgrenska Academy
Nature communications, ISSN 2041-1723, 10/2014, Volume 5, Issue 1, pp. 5068 - 5068
Journal Article